Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873387 · ClinicalTrials.gov registry record
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
A clinical trial of Pulmonary Hypertension, sponsored by Eko Devices.
- Recruiting
- Registry status
- 2,420
- Enrollment target
- 3
- Study locations
NCT05873387 is a study of Pulmonary Hypertension that is actively recruiting participants, run by Eko Devices. The registered enrollment target is 2,420 participants, above the 580-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (317% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT05873387, a study of Pulmonary Hypertension, is actively recruiting participants, sponsored by Eko Devices.
- RECRUITING
- Registry status
- 2,420 participants
- Enrollment target
- 3
- Study locations
Study Summary
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
Conditions Studied
Interventions
- DEVICE Use of Eko DUO stethoscope (paired ECG/PCG)
Study Locations (3)
Rhode Island
- Rhode Island Hospital - Providence
- The Miriam Hospital - Providence
- Providence VA Medical Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,420 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05873387
The ClinicalTrials.gov registry entry for NCT05873387 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,420 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 580-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (317% higher). The listed sponsor is Eko Devices, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Use of Eko DUO stethoscope (paired ECG/PCG) is the first listed.
NCT05873387 reports 3 study locations spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05873387 about?
NCT05873387 is a clinical study titled "Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope". The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential t...
What is the current status of trial NCT05873387?
This trial is currently recruiting. The enrollment target is 2,420 participants. The study started on 2023-07-12. Estimated completion is 2026-12.
What conditions does trial NCT05873387 study?
This clinical trial studies the following conditions: Pulmonary Hypertension.
What interventions are being tested in trial NCT05873387?
The interventions under investigation include: Use of Eko DUO stethoscope (paired ECG/PCG) (DEVICE).
Who is sponsoring clinical trial NCT05873387?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05873387 being conducted?
This trial has 3 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
-
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.